BCL2L1 and colorectal carcinoma: Our research demonstrated that LINC02595 is an oncogene in colorectal cancer (CRC) and established the presence of a LINC02595‐miR‐203b‐BCL2L1 axis in CRC, which might provide a new diagnostic biomarker and therapeutic targets for the treatment of this disease.